Vetoquinol SA Logo

Vetoquinol SA

Develops and markets veterinary medicines for companion animals and livestock.

VETO | PA

Overview

Corporate Details

ISIN(s):
FR0004186856
LEI:
969500YP0AETQIK48R39
Country:
France
Address:
Village, 70200 MAGNY-VERNOIS

Description

Vetoquinol SA is a global animal health company that researches, develops, produces, and markets veterinary medicines and non-medicinal products. The company provides solutions for both companion animals (cats and dogs) and livestock (cattle and pigs). Its product portfolio addresses a wide range of therapeutic areas, including mobility, dermatology, anti-parasitics, antibiotics, internal medicine, and behavior management. Founded in 1933, the independent, family-owned business focuses on innovation and maintaining a close relationship with veterinary professionals to support animal well-being.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-28 17:45
Quarterly financial reporting / Third quarter financial report
English 273.2 KB
2025-10-28 17:45
Information financière trimestrielle / Information financière du troisième trim…
French 260.0 KB
2025-09-11 17:45
Inside Information / News release on accounts, results
English 216.2 KB
2025-09-11 17:45
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
French 226.4 KB
2025-09-11 17:45
Informations privilégiées / Communiqué sur comptes, résultats
French 219.1 KB
2025-09-04 15:45
FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE
French 376.1 KB
2025-06-06 14:45
FORMULAIRE DE DECLARATION D'ACTONS ET DE DROITS DE VOTE
French 374.6 KB
2025-05-05 15:00
FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE
French 372.0 KB
2025-04-25 10:26
Terms of availability of the information and the report on corporate governance
English 535.3 KB
2025-04-25 10:26
Modalités de mise à disposition de l’information et du rapport sur gouvernement…
French 536.8 KB
2025-04-25 09:58
Information financière trimestrielle / Information financière du premier trimes…
French 738.5 KB
2025-04-25 09:58
Quarterly financial reporting / First quarter financial report
English 737.3 KB
2025-04-25 09:45
Information et rapport sur gouvernement d'entreprise
French 12.7 MB
2025-04-24 08:10
DEPOT DEU VETOQUINOL
French 18.6 MB
2025-03-20 17:45
Inside Information / News release on accounts, results
English 223.5 KB

Automate Your Workflow. Get a real-time feed of all Vetoquinol SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vetoquinol SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vetoquinol SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-07-25 N/A Other Sell 4,000 399,600.00 EUR
2024-07-25 N/A Other Buy 4,000 399,600.00 EUR
2024-03-21 N/A Other Sell 3,500 346,500.00 EUR
2024-03-21 N/A Other Buy 3,500 346,500.00 EUR
2024-01-03 N/A Other Buy 1,800 182,880.00 EUR
2023-11-16 N/A Other Buy 1,000 87,500.00 EUR
2023-11-13 N/A Other Sell 1,000 87,500.00 EUR
2023-09-08 N/A Other Buy 400 33,960.00 EUR

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.